DUPILUMAB IMPROVED ASTHMA CONTROL ACROSS BASELINE IMMUNOGLOBULIN E LEVELS: LIBERTY ASTHMA QUEST STUDY

被引：1
|
作者：
Carr, W.
Corren, J.
Rice, M.
Deniz, Y.
Rowe, P.
Teper, A.
Khan, A.
Kamat, S.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2019年 / 123卷 / 05期
关键词：
D O I：
10.1016/j.anai.2019.08.289
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
P223
引用
收藏
页码：S39 / S40
页数：3
相关论文
共 50 条
  • [41] Type 2 Biomarkers Associated with Dupilumab Efficacy in Patients with Uncontrolled, Moderate-To-Severe Asthma Enrolled in the Phase 3 Study LIBERTY ASTHMA QUEST
    Wenzel, S. E.
    Pavord, I.
    Zhang, B.
    Maroni, J.
    Rowe, P.
    Hamilton, J. D.
    Swanson, B. N.
    Amin, N.
    Pirozzi, G.
    Graham, N. M.
    Teper, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [42] DUPILUMAB REDUCED EXACERBATIONS AND IMPROVED LUNG FUNCTIONS IN PATIENTS WITH MODERATE-TO-SEVERE ASTHMA AND PRIOR EXACERBATIONS: LIBERTY ASTHMA TRAVERSE STUDY
    Corren, Jonathan
    Castro, Mario
    Maspero, Jorge F.
    Humbert, Marc
    Halpin, David M. G.
    Altincatal, Arman
    Pandit-Abid, Nami
    Soler, Xavier
    Siddiqui, Shahid
    Jacob-Nara, Juby A.
    Deniz, Yamo
    Rowe, Paul J.
    CHEST, 2022, 162 (04) : 1936A - 1938A
  • [43] A post hoc analysis of dupilumab efficacy in asthma patients with comorbid allergic rhinitis and chronic rhinosinusitis/nasal polyps from the LIBERTY ASTHMA QUEST study
    Maspero, J. F.
    Kuna, P.
    Ford, L. B.
    Valero Santiago, A.
    Daizadeh, N.
    Rowe, P.
    Deniz, Y.
    Kamat, S.
    Khan, A. H.
    Pandit-Abid, N.
    Ortiz, B.
    ALLERGY, 2020, 75 : 16 - 16
  • [44] Dupilumab Efficacy in Asthma Patients With FEV1 60-80% Predicted on Medium-Dose ICS: liberty asthma quest Study
    Papi, Alberto
    Pavord, Ian D.
    Fitzgerald, J. Mark
    Corren, Jonathan
    Bardin, Philip
    Park, Hae Sim
    Rice, Megan S.
    Deniz, Yamo
    Rowe, Paul
    Staudinger, Heribert
    Amin, Nikhil
    Ruddy, Marcella
    Graham, Neil M. H.
    Teper, Ariel
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [45] ASSESSMENT OF THE LONG-TERM SAFETY AND EFFICACY OF DUPILUMAB IN CHILDREN WITH ASTHMA (LIBERTY ASTHMA EXCURSION STUDY)
    Bacharier, Leonard B.
    Maspero, Jorge F.
    Katelaris, Connie H.
    Fiocchi, Alessandro
    Gagnon, Remi
    De Mir-Messa, Ines
    Guilbert, Theresa W.
    Jackson, Daniel J.
    Li, Ning
    Akinlade, Bolanle
    Laws, Elizabeth
    Mannent, Leda L. M.
    Maloney, Jennifer
    Tawo, Kelsey
    Khokhar, Faisal A.
    Hardin, Megan
    Abdulai, Raolat
    Lederer, David J.
    Robinson, Lacey B.
    CHEST, 2022, 162 (04) : 2677A - 2679A
  • [46] Dupilumab improves SNOT-22 scores in asthma patients with chronic rhinosinusitis or nasal polypsosis (CRS/NP) in LIBERTY ASTHMA QUEST
    Busse, William
    Maspero, Jorge F.
    Katelaris, Contance H.
    Saralaya, Dinesh
    Guillonneau, Sophie
    Zhang, Bingzhi
    Taniou, Christine
    Staudinger, Heribert
    Chao, Jingdong
    Amin, Nikhil
    Pirozzi, Gianluca
    Ruddy, Marcella
    Akinlade, Bolanle
    Graham, Neil M. H.
    Teper, Ariel
    Khan, Asif
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [47] Dupilumab Provides Rapid and Sustained Exacerbation Protection in Patients with Uncontrolled, Moderate-to-Severe Type 2 Inflammatory Asthma Enrolled in the LIBERTY ASTHMA QUEST Study
    Corren, J.
    Rogers, L.
    Papi, A.
    Chen, Z.
    Pandit-Abid, N.
    Rowe, P.
    Deniz, Y.
    Ortiz, B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [48] DUPILUMAB REDUCES SEVERE EXACERBATION RATE AND IMPROVES LUNG FUNCTION IN ADOLESCENT PATIENTS WITH UNCONTROLLED, MODERATE-TO-SEVERE ASTHMA: FROM THE LIBERTY ASTHMA QUEST STUDY
    Maspero, Jorge
    Fitzgerald, Mark
    Pavord, Ian
    Wenzel, Sally
    Zhang, Bingzhi
    Maroni, Jaman
    Rowe, Paul
    Amin, Nikhil
    Pirozzi, Gianluca
    Ruddy, Marcella
    Akinlade, Bolanle
    Graham, Neil
    Teper, Ariel
    CHEST, 2018, 154 (04) : 25A - 27A
  • [49] Dupilumab Treatment Produces Rapid and Sustained Improvements in FEV1 in Patients with Uncontrolled, Moderate-To-Severe Asthma from the LIBERTY ASTHMA QUEST Study
    Castro, M.
    Busse, W. W.
    Zhang, B.
    Maroni, J.
    Rowe, P.
    Amin, N.
    Pirozzi, G.
    Graham, N. M.
    Teper, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [50] Dupilumab improved lung function and reduced exacerbation rates in patients with moderate-tosevere asthma and prior exacerbations: LIBERTY ASTHMA TRAVERSE study
    Rhee, Chin Kook
    Corren, Jonathan
    Castro, Mario
    Maspero, Jorge F.
    Humbert, Marc
    Halpin, David M. G.
    Altincatal, Arman
    Pandit-Abid, Nami
    Soler, Xavier
    Siddiqui, Shahid
    Jacob-Nara, Juby A.
    Deniz, Yamo
    Rowe, Paul J.
    RESPIROLOGY, 2023, 28 : 76 - 78
12345